Fundamentals As a play to hold long, SAY is arguably a very good bet. At its current sp it has almost met the conservative Fair Value sp by Morningstar of $.06 (this after yesterday's close). That, to me, is part of the longterm attraction. It's not volatile enough nor worth enough to be manipulated by day traders and shorters. As a consequence the sp seems stable and sustainable. Barchart still has an 88% strong buy and a "strongest short term outlook" on maintaining and moving forward from its current valuation.
As the financials presented ....it has weathered the storm of the pandemic as well as could have been predicted and probably better than most expected. Clearly the influence of covid is likely to be around for no less than the first half of 2021 which means growth will be slow. Morningstar has a speculative 1-star valuation of $.15 which some might suggest is not spectacular. It is certainly achievable and would be an almost 400% increase from just one month ago.
The current sp is cheap, the company makes money, even if the bottom line is still in the red (the cost of R&D), Sparta has significant potential revenue in the pipeline (an NR on a large contract would probably see the sp double in a day) and the CEO is incredibly transparent and focused.
Sparta is not one of these "pay off your mortgage" in a day plays but has significant upside for the patient. The one year chart shows a positive trend and the volumes of late show much more interest in the stock.
GLTA!!!